fluorescein-5-isothiocyanate has been researched along with betulinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badrinath, Y; Joshi, DS; Mishra, KP; Narkar, AA; Raghuvar Gopal, DV | 1 |
| Chang, Q; Pan, R; Si, J; Tian, Z; Wu, E; Xiao, P | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and betulinic acid
| Article | Year |
|---|---|
Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Evaluation, Preclinical; Electrophoresis, Agar Gel; Fluorescein-5-isothiocyanate; Fusion Proteins, bcr-abl; Gene Expression; Humans; Inhibitory Concentration 50; Intracellular Membranes; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potentials; Mitochondria; Pentacyclic Triterpenes; Triterpenes | 2005 |
Cimicifuga foetida extract inhibits proliferation of hepatocellular cells via induction of cell cycle arrest and apoptosis.
Topics: Animals; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Betulinic Acid; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cells, Cultured; Cimicifuga; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hepatocytes; Humans; Male; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Pentacyclic Triterpenes; Plant Extracts; Triterpenes; Xenograft Model Antitumor Assays | 2007 |